Compare AUBN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUBN | XBIT |
|---|---|---|
| Founded | 1907 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.3M | 75.0M |
| IPO Year | 1996 | 2015 |
| Metric | AUBN | XBIT |
|---|---|---|
| Price | $23.53 | $2.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.2K | ★ 22.2K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 13.66 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $619,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.31 | ★ N/A |
| Revenue Growth | ★ 0.81 | N/A |
| 52 Week Low | $19.91 | $2.09 |
| 52 Week High | $29.00 | $3.61 |
| Indicator | AUBN | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 61.27 |
| Support Level | $23.01 | $2.29 |
| Resistance Level | $24.35 | $2.69 |
| Average True Range (ATR) | 0.35 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 42.57 | 58.33 |
Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.